Skip to main content
Log in

Plasma lipoprotein concentrations in ethnic populations

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

There is a complex interplay between genetic and environmental factors that influences the expression of plasma lipoprotein levels. It is therefore not surprising that differences in lipid levels have been reported between ethnic groups. There are conflicting data on racial and ethnic variations in lipids, and also limited data on the relationship between lipoprotein levels and coronary heart disease risk in specific populations. This review summarizes available data on ethnic variations in plasma lipoproteins and the potential impact on coronary morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Zemel PC, Sowers JR: Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol 1990, 66:7I-12I.

    Article  PubMed  CAS  Google Scholar 

  2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.

  3. D’Agostino RB, Russell MW, Huse DM, et al.: Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000, 139(2 Pt 1):272–281.

    Article  PubMed  CAS  Google Scholar 

  4. Stamler J, Daviglus ML, Garside DB, et al.: Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and allcause mortality and to longevity. JAMA 2000, 284:311–318.

    Article  PubMed  CAS  Google Scholar 

  5. Neaton JD, Blackburn H, Jacobs D, et al.: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992, 152:1490–1500.

    Article  PubMed  CAS  Google Scholar 

  6. Kromhout D: Serum cholesterol in cross-cultural perspective. The Seven Countries Study. Acta Cardiol 1999, 54:155–158.

    PubMed  CAS  Google Scholar 

  7. Verschuren WM, Jacobs DR, Bloemberg BP, et al.: Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995, 274:131–136.

    Article  PubMed  CAS  Google Scholar 

  8. Crook ED, Clark BL, Bradford ST, et al.: From 1960s Evans County Georgia to present-day Jackson, Mississippi: an exploration of the evolution of cardiovascular disease in African Americans. Am J Med Sci 2003, 325:307–314.

    Article  PubMed  Google Scholar 

  9. Clark LT, Ferdinand KC, Flack JM, et al.: Coronary heart disease in African Americans. Heart Dis 2001, 3:97–108.

    Article  PubMed  CAS  Google Scholar 

  10. Tyroler HA, Glueck CJ, Christensen B, et al.: Plasma high-density lipoprotein cholesterol comparisons in black and white populations The Lipid Research Clinics Program Prevalence Study. Circulation 1980, 62:99–107.

    CAS  Google Scholar 

  11. Sprafka JM, Norsted SW, Folsom AR, et al.: Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology 1992, 3:156–163.

    PubMed  CAS  Google Scholar 

  12. Webber LS, Srinivasan SR, Wattigney WA, et al.: Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991, 133:884–899.

    PubMed  CAS  Google Scholar 

  13. Brown SA, Hutchinson R, Morrisett J, et al.: Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993, 13:1139–1158.

    PubMed  CAS  Google Scholar 

  14. Vega GL, Clark LT, Tang A, et al.: Hepatic lipase activity is lower in African American than in white American men: Effects of 5' flanking polymorphism in the hepatic lipase gene. J Lipid Res 1998, 39:228–232. This study examined the relationship between hepatic lipase activity, plasma HDL cholesterol concentrations, and a hepatic lipase polymorphism (514T) in black and white American men. HDL choleserol concentrations were significantly higher in black men and mean postheparin plasma hepatic lipase activity was significantly lower in black than in white men. The 514T hepatic lipase allele was associated with low hepatic lipase activity in both populations, and was threefold more common among blacks than whites.

    PubMed  CAS  Google Scholar 

  15. Nie L, Niu S, Vega GL, et al.: Three polymorphisms associated with low hepatic lipase activity are common in African Americans. J Lipid Res 1998, 39:1900–1903.

    PubMed  CAS  Google Scholar 

  16. Metcalf PA, Sharrett AR, Folsom AR, et al.: African Americanwhite differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1998, 148:750–760.

    PubMed  CAS  Google Scholar 

  17. Donahue RP, Jacobs DR Jr, Sidney S, et al.: Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis 1989, 9:656–664.

    PubMed  CAS  Google Scholar 

  18. Pablos-Mendez A, Mayeux R, Ngai C, et al.: Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997, 17:3534–3541.

    PubMed  CAS  Google Scholar 

  19. Rubins HB, Robins SJ, Collins D, et al.: Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995, 75:1196–1201.

    Article  PubMed  CAS  Google Scholar 

  20. O’Brien R: Biological importance of low-density-lipoprotein subfractions. J Cardiovasc Risk 1994, 1:207–211.

    PubMed  CAS  Google Scholar 

  21. Kral BG, Becker LC, Yook RM, et al.: Racial differences in lowdensity lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis 2001, 11:325–337.

    PubMed  CAS  Google Scholar 

  22. Uterman G: The mysteries of lipoprotein(a). Science 1989, 246:904–910.

    Article  Google Scholar 

  23. Gunther MF, Catherin AR, Angelo MS: Heterogeneity of human lipoprotein(a). J Biol Chem 1984, 259:11470–11478.

    Google Scholar 

  24. Para HG, Luyey I, Buramoue C, et al.: Black-white differences in serum lipoprotein(a) levels. Clin Chim Acta 1987, 167:27–31.

    Article  Google Scholar 

  25. Scanu AM: Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA, 1992, 267:3326–3329.

    Article  PubMed  CAS  Google Scholar 

  26. Macovina SM, Koshchinsky ML: Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 1998, 82:57U-66U.

    Article  Google Scholar 

  27. Rim L, Ali B, Slim BA, Bechir Z: Lipoprotein(a): a new risk factor for coronary artery disease. Tunis Med 2000, 78:648–652.

    PubMed  CAS  Google Scholar 

  28. Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993, 270:2195–2199.

    Article  PubMed  CAS  Google Scholar 

  29. Wild SH, Fortmann SP, Marcovina SM: A prospective casecontrol study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 1997, 17:239–245.

    PubMed  CAS  Google Scholar 

  30. Sandholzer C, Saha N, Kark JD, et al.: Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 1992, 12:1214–1226.

    PubMed  CAS  Google Scholar 

  31. Moliterno DJ, Jokinen EV, Miserez AR, et al.: No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 1995, 15:850–855.

    PubMed  CAS  Google Scholar 

  32. Sorrentino MJ, Vielhauer C, Eisenbart JD, et al.: Plasma lipoprotein(a) protein concentration and coronary artery disease in black patients compared with white patients. Am J Med 1992, 93:658–662.

    Article  PubMed  CAS  Google Scholar 

  33. Marcovina SM, Albers JJ, Wijsman E, et al.: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996, 37:2569–2585.

    PubMed  CAS  Google Scholar 

  34. Paultre F, Pearson TA, Weil HF, et al.: High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000, 20:2619–2624. The authors investigated the hypothesis that apo(a) isoform size determines the association between Lp(a) and CHD. They related Lp(a) levels, apo(a) isoforms, and the levels of Lp(a) associated with different apo(a) isoforms to the presence of CHD in 576 white and black men and women. Elevated Lp(a) levels (≥ 30 mg/dL) were found in 26% of whites and 68% of blacks, and of those, 80% of whites but only 26% of blacks had a small apo(a) isoform. Elevated Lp(a) levels with small apo(a) isoforms were significantly associated with CAD (P < 0.01) in black and white men but not in women.

    PubMed  CAS  Google Scholar 

  35. Lillie-Blanton M, Martinez RM, Taylor AK, Robinson BG: Latina and African American women: continuing disparities in health. Int J Health Serv 1993, 23:555–584.

    Article  PubMed  CAS  Google Scholar 

  36. O’Hare WP: Hispanic Americans in the 1980s: mainstream or minority? Popul Today 1989, 17:6–8.

    Google Scholar 

  37. Bureau of the Census: Statistical Tables for the Hispanic Origin Population from the March 1994 Current Population Survey. Washington, DC: Bureau of the Census; 1995.

    Google Scholar 

  38. Aguilar-Salinas CA, Olaiz G, Valles V, et al.: High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001, 42:1298–1307. Information was obtained on 15,607 subjects, aged 20 to 69 years. Mean total cholesterol concentration in this cohort was185 mg/dL, mean TG level was 212 mg/dL, mean HDL level was 40 mg/dL, and mean LDL concentration was 118 mg/dL.

    PubMed  CAS  Google Scholar 

  39. Hanis CL, Hewett-Emmett D, Douglas TC, Schull WJ: Lipoprotein and apolipoprotein levels among Mexican-Americans in Starr County, Texas. Arterioscler Thromb 1991, 11:123–129.

    PubMed  CAS  Google Scholar 

  40. Reaven P, Nader PR, Berry C, Hoy T: Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers. Pediatrics 1998,101:E12.

    Article  PubMed  CAS  Google Scholar 

  41. Bermudez OI, Velez-Carrasco W, Schaefer EJ, Tucker KL: Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 2002, 76:1214–1221.

    PubMed  CAS  Google Scholar 

  42. Haffner SM, D’Agostino R Jr., Goff D, et al.: LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999, 19: 2234–2240. The authors examined LDL size in 1571 subjects from the Insulin Resistance Atherosclerosis Study. LDL size was significantly different by ethnic group (blacks 262.1 ± 0.6, Hispanics 257.6 ± 0.6, and non-Hispanic whites 259.2 ± 0.4; P < 0.001).

    PubMed  CAS  Google Scholar 

  43. Chiu L, Hamman RF, Kamboh MI: Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic whites and Hispanics. Hum Biol 2000, 72:821–835.

    PubMed  CAS  Google Scholar 

  44. Harwell TS, Moore K, McDowall JM, et al.: Cardiovascular risk factors in Montana American Indians with and without diabetes. Am J Prev Med 2003, 24:265–269.

    Article  PubMed  Google Scholar 

  45. Howard BV, Lee ET, Cowan LD, et al.: The rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation 1999, 99:2389–2395.

    PubMed  CAS  Google Scholar 

  46. Yurgalevitch SM, Kriska AM, Welty TK, et al.: Physical activity and lipids and lipoproteins in American Indians ages 45–74. Med Sci Sports Exerc 1998, 30:543–549.

    PubMed  CAS  Google Scholar 

  47. Freedman DS, Serdula MK, Percy CA, et al.: Obesity, levels of lipids and glucose, and smoking among Navajo adolescents. J Nutr. 1997, 127(10 Suppl):2120S-2127S. A total of 160 12- to 19-year-old Navajo subjects were examined. Levels of total cholesterol and blood pressure were similar to those in the general US population, but Navajo adolescents had a 5- to 10-mg/ dL lower median level of HDL cholesterol, and a 30 mg/dL higher median TG level.

    PubMed  CAS  Google Scholar 

  48. Wang W, Hu D, Lee ET, et al.: Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study. Ann Epidemiol 2002, 12:107–114.

    Article  PubMed  Google Scholar 

  49. Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and therapy. Clin Cardiol 1995, 18:131–135. This article summarizes information on CHD in Asian Indians. The author emphasizes that although the incidence of classic risk factors is low in this population, high TG, low HDL levels, high Lp(a) levels, and hyperinsulinemia all show a substantial prevalence in this population.

    Article  PubMed  CAS  Google Scholar 

  50. Miller GJ, Kotecha S, Wilkinson WH, et al.: Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis 1988, 70:63–72.

    Article  PubMed  CAS  Google Scholar 

  51. Hoogeveen RC, Gambhir JK, Gambhir DS, et al.: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001, 42:631–638.

    PubMed  CAS  Google Scholar 

  52. Cruickshank JK, Cooper J, Burnett M, et al.: Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991, 338:842–847.

    Article  PubMed  CAS  Google Scholar 

  53. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382–386.

    Article  PubMed  CAS  Google Scholar 

  54. Raji A, Seely EW, Arky RA, Simonson DC: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001, 86:5366–5371.

    Article  PubMed  CAS  Google Scholar 

  55. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP: Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 1999, 19:2749–2755.

    PubMed  CAS  Google Scholar 

  56. Isser HS, Puri VK, Narain VS, et al.: Lipoprotein (a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Indian Heart J 2001, 53:463–466.

    PubMed  CAS  Google Scholar 

  57. Velmurugan K, Deepa R, Ravikumar R, et al.: Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in type 2 diabetic patients in south India. Diabetic Medicine 2003, 20:455–461.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watson, K.E. Plasma lipoprotein concentrations in ethnic populations. Curr Cardiol Rep 5, 483–487 (2003). https://doi.org/10.1007/s11886-003-0111-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-003-0111-3

Keywords

Navigation